Urinary cotinine measurement patients Buerger disease effects active passive smoking disease process Buerger disease smoking objective analysis smoke-associated problems study cotinine major metabolite nicotine sensitive marker measure levels active smoking exposure nonsmokers smoke long half-life cotinine levels noninvasive means urine urinary cotinine levels patients Buerger disease smokers urinary cotinine levels ng/mg creatinine passive smokers levels ng/mg creatinine nonsmokers noticeable passive smoking levels ng/mg creatinine smokers passive smokers nonsmokers course disease initial treatment hospital Seven smokers none passive smokers nonsmokers aggravation disease nonsmokers aggravation smokers smoke workplace time relapse significant difference aggravation rate smokers group groups smokers patients conditions cotinine levels patients stage remission 